| physical trauma |
phenotype |
3 |
2 |
physical abuse, physical assault, physical violence |
| physicians |
cohort |
3 |
— |
physicians |
| physiological dependence |
phenotype |
4 |
4 |
|
| PI3K |
gene |
5 |
3 |
PI(3)K, p100δ isoform of catalytic subunit of PI3K, phosphatidylinositol 3-kinase, phosphoinositide 3-kinase |
| PICALM |
gene |
3 |
2 |
|
| picrotoxin |
drug |
10 |
6 |
GABA-A receptor antagonist picrotoxin, PTX |
| PIK3R1 |
gene |
3 |
2 |
|
| pioglitazone |
drug |
4 |
3 |
PPARγ agonist pioglitazone |
| piRNA |
drug |
2 |
1 |
Piwi-interacting RNA, piRNAs |
| PKA |
drug |
9 |
8 |
PKA, PRKACA, Protein Kinase A, Protein kinase A, cAMP-dependent kinase PKA, cAMP-dependent protein kinase, protein kinase A |
| PKC |
gene |
5 |
5 |
PKC isozymes, PKCs, Protein Kinase C, Protein kinase C, atypical PKCs, conventional PKCs, novel PKCs, protein kinase C |
| PKNOX2 |
gene |
4 |
3 |
PBX/Knotted 1 Homeobox 2 |
| place preference |
phenotype |
4 |
2 |
conditioned place preference, ethanol-mediated place preference |
| planning |
phenotype |
8 |
5 |
planning |
| plasmids |
drug |
3 |
— |
|
| Play behavior |
phenotype |
4 |
3 |
play |
| Plcb1 |
gene |
3 |
2 |
PLCβ, Plcb1 |
| PLCL1 |
gene |
3 |
2 |
phospholipase C-like 1 |
| PLCO |
cohort |
3 |
2 |
PLCO participants, Prostate Lung Colorectal Ovarian Cancer Screening Trial, Prostate Lung Colorectal and Ovarian Cancer Screening Trial, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
| Plink |
drug |
17 |
6 |
PLINK software, PLINK17 |
